Back to results
US 2013/0274346 A1Published application
Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
AssigneeNapo Pharmaceuticals, Inc.
InventorPravin R. CHATURVEDI
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to compositions and methods for oral delivery of nordihydroguaiaretic acid (NDGA). More particularly, the present invention relates to pharmacologically optimized multimodal drug delivery systems for orally administered NDGA and methods for preparation and use thereof.
Claims9
A method for treating a metabolic disorder in a subject comprising oral administration of a drug delivery system for nordihydroguiaretic acid (NDGA), comprising:
- a first portion of NDGA that is released in the stomach;
- and
- a second portion of NDGA that is released in the small intestines;
- wherein at least 90% of the NDGA is absorbed before reaching the large intestines, and wherein the NDGA absorption exhibits multimodal delivery kinetics.
1 more element
Dependencies are inferred from the claim text.